Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.
Innate to receive $5M milestone payment from AstraZeneca
The information center has been established with the aim of providing Fortis Healthcare’s world-class healthcare services accessible to the people of Tirupati.
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Subscribe To Our Newsletter & Stay Updated